BioLight Israeli Life Sciences Investments
Tel Aviv · Founded 2005
About BioLight Israeli Life Sciences Investments
BioLight Life Sciences Ltd. is a leading company investing in companies and managing projects relating to eye disease and their treatment. BioLight’s portfolio companies engage in advanced medical devices, medication, diagnostics and digital medicine and all exemplify the enormous potential of Israeli innovation in these fields. Development and commercialization of the company’s ophthalmic technologies and products. The ophthalmic products developed by the companies in the BioLight group are aimed at innovative diagnosis and treatments for the needs of patient groups suffering from eye diseases. The different ophthalmic products are in various commercialization and clinical (or pre-clinical) phases. BioLight intends, in line with its financial capabilities, to continue supplementing and expanding the array of technologies and products under development, whether through investment in additional companies or through business development and expansion of the activity of the existing companies.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $16.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2018)
- Ticker: tlv:BOLT
- Website: bio-light.co.il
- Phone: +972 7 327 53400
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biolight-israeli-life-sciences-investments-107615 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.